Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trial
Daiichi Sankyo
Harry P Erba; Pau Montesinos; Hee-Je Kim; Elżbieta Patkowska; Radovan Vrhovac; Pavel Žák; Po-Nan Wang; Tsvetomir Mitov; James Hanyok; Yasser Mostafa Kamel; Jaime E Connolly Rohrbach; Li Liu; Aziz Benzohra; Arnaud Lesegretain; Jorge Cortes; Alexander E Perl; Mikkael A Sekeres; Hervé Dombret; Sergio Amadori; Jianxiang Wang; Mark J Levis; Richard F Schlenk; QuANTUM-First Study Group